Comparison of Ibuprofen with Ketorolac on the Control of Renal Colic Pain: A Meta-Analysis of Randomized Controlled Studies.

Fuxian Cai, Yougang Liao, Shichun Jiang, Yuan Cao, Yaodong Wang

Journal: Urology journal 2024;20(6):379-384

PMID: 37634069

Abstract

PURPOSE

The comparison of ibuprofen with ketorolac remains controversial for the pain control of renal colic. We therefore conduct this meta-analysis to compare the analgesic efficacy of ibuprofen with ketorolac for renal colic.

METHODS

We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through December 2022 for randomized controlled trials (RCTs) assessing the analgesic efficacy of ibuprofen in comparison with ketorolac for renal colic. This meta-analysis was performed using the random-effect or fixed-effect model based on the heterogeneity.

RESULTS

Four RCTs were included in the meta-analysis. In patients with renal colic pain, intravenous ibuprofen and ketorolac produced comparable pain scores at 15 min (MD = -0.46; 95% CI = -1.24 to 0.31; P = 0.24), 30 min (MD = -0.81; 95% CI = -1.75 to 0.31; P = 0.09), 60 min (MD=-0.63; 95% CI = -1.40 to 0.13; P = 0.10) and 120 min (MD = -0.74; 95% CI = -2.18 to 0.70; P = 0.31), as well as adverse events (OR = 0.95; 95% CI = 0.61 to 1.49; P = 0.83).

CONCLUSION

Ibuprofen can obtain comparable analgesic efficacy to ketorolac for renal colic pain.

Address: Department of Urology, Mianyang Central Hospital, China. [email protected].; Department of Urology, Mianyang Central Hospital, China. [email protected].; Department of Urology, Mianyang Central Hospital, China. [email protected].; Department of Urology, Mianyang Central Hospital, China. [email protected].; Department of Urology, Mianyang Central Hospital, China. [email protected].

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.